相关实验视频

Updated: May 20, 2025

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
11:34

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on: December 5, 2017

12.4K

瘤芽:乳腺癌的新型预后标志物,与组织病理和免疫组织化学参数的相关性

Poornima Manimaran1, Ashini Shah1, Amisha Gami1

  • 1Department of Oncopathology, Gujarat Cancer Research Institute, Ahmedabad, India.

South Asian journal of cancer
|March 24, 2025
PubMed
概括

乳腺癌中高瘤芽密度与晚期瘤和淋巴结分期相关,表明预后较差. 这种组织学特征是一个重要的预后指标,应在乳腺癌报告中考虑.

关键词:
他的2/neu.乳腺癌,乳腺癌.无事件生存率 无事件生存率激素受体 激素受体 激素受体瘤芽是一种瘤.

更多相关视频

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

7.8K
Predictive Immune Modeling of Solid Tumors08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

6.8K

相关概念视频

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K